Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 8.02B P/E - EPS this Y 51.60% Ern Qtrly Grth -
Income -195.05M Forward P/E 175.73 EPS next Y 38.70% 50D Avg Chg 4.00%
Sales 4.32B PEG 0.03 EPS past 5Y - 200D Avg Chg -7.00%
Dividend N/A Price/Book 7.40 EPS next 5Y -657.60% 52W High Chg -34.00%
Recommedations 2.60 Quick Ratio 1.46 Shares Outstanding 411.06M 52W Low Chg 29.00%
Insider Own 1.55% ROA -8.44% Shares Float 304.09M Beta 0.50
Inst Own 109.60% ROE -22.95% Shares Shorted/Prior 46.02M/46.96M Price 19.33
Gross Margin 1.61% Profit Margin -6.08% Avg. Volume 3,608,359 Target Price 7.89
Oper. Margin -15.56% Earnings Date May 7 Volume 3,134,254 Change 5.63%
About agilon health, inc.

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

agilon health, inc. News
04/16/24 agilon health Sets Date to Report First Quarter 2024 Financial Results
03/16/24 Bullish agilon health Insider Buying Worth US$747.9k Yet To Pay Off
03/08/24 Do You Think agilon health (AGL)’s Probability of Success Has Decreased?
02/28/24 agilon health, inc. (NYSE:AGL) Q4 2023 Earnings Call Transcript
02/27/24 Agilon (AGL) Reports Q4 Earnings: What Key Metrics Have to Say
02/27/24 Agilon Health (AGL) Reports Q4 Loss, Tops Revenue Estimates
02/27/24 Agilon Health Inc (AGL) Faces Headwinds Despite Revenue Surge in Q4 2023
02/27/24 agilon health Reports Fourth Quarter 2023 Results
02/27/24 AGL Credit Management Has Three CLOs Named Finalists for DealCatalyst's 2024 Deals of the Year Awards
02/26/24 Seeking Clues to Agilon (AGL) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
02/21/24 agilon health to Participate in the 44th Annual Cowen Health Care Conference
02/20/24 Analysts Estimate Agilon Health (AGL) to Report a Decline in Earnings: What to Look Out for
02/09/24 agilon health Sets Date to Report Fourth Quarter and Full Year 2023 Financial Results
02/08/24 agilon health Announces Chief Medical Officer Transition
02/06/24 The 7 Best Penny Stocks for 200% Returns
01/09/24 February Risk Alert: 3 Stocks to Unload Now to Protect Your Portfolio
01/05/24 agilon health Announces Tim Bensley to Retire as CFO
01/05/24 agilon health Provides 2023 Guidance Update, Initial 2024 View
01/03/24 15 Best Growth Stocks to Buy Under $25
12/21/23 agilon health to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
AGL Chatroom

User Image Digital_Waffle_Pirate Posted - 04/30/24

$AGL guess we can say see ya to $4s

User Image ali123456 Posted - 04/29/24

$AGL very bullish graph

User Image ali123456 Posted - 04/29/24

$AGL allot of insider buying

User Image Loveleaps55 Posted - 04/23/24

$AGL interesting price action.. huge dump to break the upward momentum.. probably cover slowly during the day..

User Image LetsgoRandy Posted - 04/22/24

$AGL Company beats earnings and bulls are potentially looking to gap fill $11+. Company delivers another disastrous ER and shareholders might end up in ER. This becomes a buyout candidate at some point... Their revenue more than doubled in three years from 1.8B -> 2.7B -> 4.3B in 2023. All they need is a little cost control to turn profits and company starts huge reversal IMHO.

User Image Loveleaps55 Posted - 04/22/24

$AGL bouncing between 20 dma and 50dma. Earnings will set a new trend

User Image Loveleaps55 Posted - 04/22/24

$AGL 47M share short and earnings coming up. Should be interesting..

User Image DonCorleone77 Posted - 04/22/24

$AGL Agilon Health initiated with a Neutral at Citi Citi initiated coverage of Agilon Health with a Neutral rating and $6 price target. The analyst says Agilon is in a "precarious position," as it currently has very little flexibility in its model since it is 100% dedicated to full capitation in Medicare Advantage. To become profitable, the market environment will have to materially improve, which is unlikely, or Agilon must renegotiate its contracts, the analyst tells investors in a research note. Citi does not think Agilon has the negotiating power to materially improve its contracts.

User Image dtrm8 Posted - 04/19/24

$AGL this sheet is crazy manipulated nit that I didn’t guess, my limit order just blew off, wish I had adjusted.

User Image _www_larval_com_ Posted - 04/19/24

$AGL just reverted -4% lower to 0% (~3Mv) a few minutes ago, 04/19 options, follow for more volatility.

User Image Digital_Waffle_Pirate Posted - 04/19/24

$AGL continue

User Image dtrm8 Posted - 04/19/24

$AGL looking for some correction, may enter at low 5s

User Image dojidad Posted - 04/19/24

$AGL so tempting. Nice setup, but I have to stick by my charting. I'm not interested under the 50-day (red line), but it does look good. There's plenty of room after 6.01. Patience is the word of the day.

User Image BinTraden Posted - 04/18/24

$$AGL another largely negative day on the market and this continues to get bought up, lovin it!! I'm expecting a little consolidation here in this range 5.25-5.50

User Image BinTraden Posted - 04/17/24

$AGL wow on a such a negative day for the market, this sure has some strong buying power all day! Bodes very well for this sub $5 level. I'm riding some buy wish I had more..... so far. Thanks to digital waffle pirate for bringin attention to this ticker.

User Image learnfrommistake1 Posted - 04/17/24

$AGL I think it will at least run to 5.50 and based on the prices action there it might go ballistic or correct back

User Image Stock_Titan Posted - 04/16/24

$AGL agilon health Sets Date to Report First Quarter 2024 Financial Results https://www.stocktitan.net/news/AGL/agilon-health-sets-date-to-report-first-quarter-2024-financial-flar3aogxxqc.html

User Image Loveleaps55 Posted - 04/16/24

$AGL The BIG question is did we hit the bottom yesterday and are now headed higher or is this another trap for the bulls like the $5’s last week?

User Image Loveleaps55 Posted - 04/16/24

$AGL whoever bought pre-mkt got scammed..

User Image Loveleaps55 Posted - 04/15/24

$AGL $4.44.. will that hold?

User Image Loveleaps55 Posted - 04/15/24

$AGL Look at the open volume of puts at $7.5 for expiration this week.. someone is making a killing on the $7.5 puts

User Image Digital_Waffle_Pirate Posted - 04/15/24

$AGL Come to $4.

User Image Loveleaps55 Posted - 04/15/24

$AGL looks like it’s going to test precious low of $4.44.

User Image Stonkey Posted - 04/15/24

$AGL Hopeless POS going straight to zero......

User Image Digital_Waffle_Pirate Posted - 04/12/24

$AGL come to $4… I’m not buying $4.5 again

User Image Digital_Waffle_Pirate Posted - 04/09/24

$AGL chugga chugga chugga chugga, where's $4 tho? I was still hungry.

User Image Stan_Vick Posted - 04/07/24

NEW Investor Claim | $AGL investor filed a class action in New York against agilon health Inc. for overstating business prospects. In January, the profit forecast cut caused $AGL to fall 28%, losing $1.4B in shareholder value. You can join the case and be notified about potential recovery here => https://11thestate.com/cases/agilonhealth-investor-suit

User Image Digital_Waffle_Pirate Posted - 04/05/24

$AGL $4 adds, legooooo

User Image GasD Posted - 04/03/24

$AGL Difficult to understand why this stock is so punished. Why such a decline within several months only ? 4B$ sales, largely increasing months after months + reduced losses announced this year. Probably very profitable next year... I don't understand.

User Image Stonkey Posted - 04/03/24

$AGL Hopeless POS going straight to zero.....

Analyst Ratings
Citigroup Neutral Apr 22, 24
Barclays Underweight Mar 6, 24
Truist Securities Hold Feb 29, 24
Benchmark Buy Feb 29, 24
Evercore ISI Group In-Line Feb 28, 24
RBC Capital Outperform Feb 28, 24
TD Cowen Market Perform Feb 26, 24
Stifel Hold Feb 22, 24
Wolfe Research Peer Perform Jan 8, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
WILLIAMS RONALD A Director Director Jan 05 Option 2 1,100,000 2,200,000 3,564,414 01/09/24
Schwaneke Jeffrey A. Director Director Nov 29 Buy 11.22 22,300 250,206 31,931 11/30/23
Shaker Benjamin Chief Markets Office.. Chief Markets Officer Sep 12 Sell 18.02 37,500 675,750 79,543 09/14/23
Shaker Benjamin Chief Markets Office.. Chief Markets Officer Sep 12 Option 3.79 37,500 142,125 98,293 09/14/23
Gertsch Timothy Chief Accounting Off.. Chief Accounting Officer Sep 11 Sell 18.61 26,250 488,512 17,121 09/13/23
Gertsch Timothy Chief Accounting Off.. Chief Accounting Officer Sep 11 Option 6.75 26,250 177,188 25,871 09/13/23
Shaker Benjamin Chief Markets Office.. Chief Markets Officer Apr 17 Sell 28.09 50,000 1,404,500 79,543 04/19/23
Shaker Benjamin Chief Markets Office.. Chief Markets Officer Apr 17 Option 2.33 50,000 116,500 104,543 04/19/23
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer Jan 05 Sell 15.48 5,396 83,530 10,426 01/09/23
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer Jan 05 Option 8.99 5,396 48,510 13,124 01/09/23
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer Dec 15 Option 6.74 5,398 36,383 15,824 01/09/23
Shaker Benjamin Chief Markets Office.. Chief Markets Officer Nov 16 Option 3 37,500 112,500 44,375 11/18/22
Shaker Benjamin Chief Markets Office.. Chief Markets Officer Nov 16 Sell 17.73 37,500 664,875 25,625 11/18/22
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer Nov 16 Option 4.49 10,792 48,456 15,822 11/18/22
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer Nov 16 Sell 17.97 10,792 193,932 10,426 11/18/22
Shaker Benjamin Chief Markets Office.. Chief Markets Officer Oct 19 Sell 20.37 50,000 1,018,500 25,625 10/21/22
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer Oct 14 Option 4.49 10,792 48,456 15,822 10/18/22
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer Oct 14 Sell 21.79 10,792 235,158 10,426 10/18/22
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer Oct 03 Option 4.49 16,188 72,684 18,520 10/05/22
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer Oct 03 Sell 23.72 16,188 383,979 10,426 10/05/22
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer Sep 26 Sell 22.8 16,188 369,086 10,853 09/28/22
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer Sep 26 Option 4.49 16,188 72,684 21,645 09/28/22
CD&R Investment Associates IX,... 10% Owner 10% Owner Aug 11 Sell 24.35 11,337,500 276,068,125 194,611,308 08/12/22
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer Aug 04 Option 4.49 16,188 72,684 18,947 08/08/22
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer Aug 04 Sell 25.02 16,188 405,024 10,853 08/08/22
Desai Veeral Chief Strategy & Dev.. Chief Strategy & Dev. Officer Jul 21 Option 1 79,768 79,768 357,979 07/25/22
Desai Veeral Chief Strategy & Dev.. Chief Strategy & Dev. Officer Jul 21 Sell 27.5 79,768 2,193,620 278,211 07/25/22
Desai Veeral Chief Strategy & Dev.. Chief Strategy & Dev. Officer Jul 07 Option 1 319,071 319,071 597,282 07/11/22
Desai Veeral Chief Strategy & Dev.. Chief Strategy & Dev. Officer Jul 07 Sell 25 319,071 7,976,775 278,211 07/11/22
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer May 27 Option 4.49 10,792 48,456 16,249 06/01/22
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer May 27 Sell 19.67 10,792 212,279 10,853 06/01/22
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer Apr 27 Option 4.49 10,792 48,456 16,249 04/29/22
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer Apr 27 Sell 18.49 10,792 199,544 10,853 04/29/22
Desai Veeral Chief Strategy & Dev.. Chief Strategy & Dev. Officer Apr 21 Option 1 106,357 106,357 305,000 04/25/22
Desai Veeral Chief Strategy & Dev.. Chief Strategy & Dev. Officer Apr 21 Sell 20.59 106,357 2,189,891 278,211 04/25/22
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer Apr 18 Option 4.49 12,773 57,351 17,149 04/20/22
Kornitzer Benjamin Chief Med. & Quality.. Chief Med. & Quality Officer Apr 18 Sell 22.39 12,773 285,987 10,853 04/20/22
Wulf John William Director Director Mar 15 Sell 19.11 30,808 588,741 116,456 03/16/22
Shaker Benjamin Chief Markets Office.. Chief Markets Officer Mar 14 Option 3 160,994 482,982 146,073 03/16/22
Shaker Benjamin Chief Markets Office.. Chief Markets Officer Mar 14 Sell 20.19 160,994 3,250,469 66,616 03/16/22
Halkias Theodore Chief Business Offic.. Chief Business Officer Dec 23 Option 1 26,725 26,725 11,017 12/28/21
Halkias Theodore Chief Business Offic.. Chief Business Officer Dec 23 Sell 27.53 26,725 735,739 5,434 12/28/21